Health Decisions CEO Explores High-Velocity Adaptive Clinical Research June 23 at DIA
According to Rosenberg, rising development costs, reimbursement pressures, and the global economic environment make the time- and cost-saving benefits of adaptive clinical research more important than ever. “Applying adaptive principles to study design as well as day-to-day operations presents an immediate promise of a dramatically faster, more efficient development pathway,” says Rosenberg. “We can eliminate poor candidates earlier, get good products to market faster, and make it financially attractive to focus on smaller, more individualized populations, including individualized therapies.”
The Practice of Adaptive Research will include the following presentations from industry experts:
• “Operational Adaptations: Running Tighter, Faster Studies,” presented by Mike Ford, director of data management at Health Decisions
• “Drug Supply in Adaptive Studies,” presented Michael Krams, MD, vice president of Adaptive Trials and Applied Program Strategies at Wyeth
• "Statistical Issues,” presented by Roger J. Lewis, MD, PhD, Professor of Medicine, Department of Emergency Medicine at Harbor UCLA Medical Center
• “Financial Benefits of Adaptive,” presented by Michael Rosenberg, MD, MPH, president and CEO of Health Decisions
The Practice of Adaptive Research is part of the R&D Strategy (RD) track, and takes place June 23 from 10:00 – 11:30 a.m. PST in Room 14B. To view the abstract, please visit http://www.diahome.org/DIAHOME/FlagshipMeetings/SearchSesTut.aspx?productID=18912&rpex=N&evtyp=SESSION&chr=Michael&ia=ALL&meetingid=17194.